Indications
treatment of cholesterol and hypercholesterolaemia
Composition
- Active substance
- mipomersen sodium
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Kynamro
- Active substance
- mipomersen sodium
- ATC code
- C10AX11
- Therapeutic area
- Hypercholesterolemia
- Marketing authorisation holder
- Genzyme Europe BV
- Status
- Refused
- Refused
- 29 May 2013
- EMA product number
- EMEA/H/C/002429